PharmaCompass

wins backing for Crohn's indication
News Flash:- Pharmaceutical
to the European Medicines Agency (EMA) are backing approval of Janssen\'s Stelara, bringing the drug closer to becoming the first interleukin (IL)-12/23 inhibitor licensed for Crohn\'s disease.
http://ow.ly/GNWw304psvE www.pharmacompass.com

fires off another lawsuit against a Lantus biosimilar
News Flash:- & ; Merck & Co.
has rushed to the defence of blockbuster basal insulin product Lantus in the once again, filing a patent infringement lawsuit against Merck & Co.
www.pharmacompass.com http://ow.ly/gIZE304psv9

Drug Discounts Haven't Materialized Hospitals Say
News Flash:- , Nitropress & Pharmaceuticals International, Inc.
after Valeant Pharmaceuticals International Inc. said it would make discounts available to .S. hospitals for two high-priced heart , some medical centers say they have yet to see a cent of savings.
www.pharmacompass.com http://ow.ly/Sgv2304psks

sells anaesthesia portfolio to Aspen
News Flash:- ; Aspen Oss B.V.
plc (GSK) has announced a series of agreements with Aspen aligned with GSK\'s strategy of simplification through focusing on core therapeutic areas
www.pharmacompass.com http://ow.ly/24AR304psij

siponimod hits targets in MS trial
News Flash:- Pharma AG
has unveiled further findings from a late-stage trial of its experimental multiple sclerosis BAF312 (siponimod), showing that the cut the risk of disability progression in adults with secondary progressive forms of the disease.
www.pharmacompass.com http://ow.ly/4uFq304prwC

Reddy's Expands Strategic Collaboration with Amgen
News Flash:- Reddys Laboratories; Amgen Inc
Reddy\'s Laboratories has announced that it has expanded its strategic collaboration with Amgen, one of the world\'s leading independent biotechnology companies, to market and distribute three of Amgen\'s medicines in India in the therapy areas of oncology and osteoporosis. Under the terms of the collaboration, Dr Reddy\'s will commercialise XGEVA(denosumab), Vectibix (panitumumab) and Prolia (denosumab) in .
www.pharmacompass.com http://ow.ly/3V7I304pqwm

caught in legal tussle over 'patent infringement'
News Flash:- Ltd
decided to take legal action after Lupin filed an abbreviated new drug application (Anda) for a generic version of Pennsaid
www.pharmacompass.com http://ow.ly/wsQM304pqwz

.S. FDA approves Bayer contraceptive device Kyleena
News Flash:- & Pharma AG
.S. and Administration approved Bayer AG\'s hormonal contraceptive device, Kyleena, to prevent pregnancy for up to five years, the German company said on Monday.
www.pharmacompass.com http://ow.ly/2PMn304pqbk

partners Takeda for chikungunya vaccine
News Flash:- PHARMS USA; Takeda GmbH
firm ZydusBSE -0.84 % Cadila today announced partnership with \'s Takeda Pharmaceutical Company Ltd to develop vaccine for .
www.pharmacompass.com http://ow.ly/kren304pqbz

surges on heavy volumes
News Flash:- Limited
.S. Pfizer Inc\'s breast cancer drug, Ibrance, should be given marketing approval, an advisory committee at the European Medicines Agency recommended.
www.pharmacompass.com http://ow.ly/VcaU304kzlE

Comments On Discount And Rebate Program For Nitropress And Isuprel
News Flash:- , Isuprel & Pharmaceuticals International, Inc.
#(DRL) has expanded its strategic collaboration with -based independent biotechnology firm Amgen to market and distribute in three of latter\'s medicines, used in the therapy areas of oncology and osteoporosis.
www.pharmacompass.com http://ow.ly/6izk304kzp1

Biotech's Bestie Celgene (CELG) Be Getting Ready to Unveil Another Deal?
Mexico Attorney General Hector Balderas has sued Bristol-Myers Squibb Co and Sanofi SA\'s .S. arm for overstating the effectiveness of and concealing the risks of their blood thinner Plavix.
www.pharmacompass.com http://ow.ly/e8iU304kzpD